Two of the Pittsburgh Steelers’ biggest stars, Hines Ward and Troy Polamalu, used their own blood in an innovative injury treatment before winning the Super Bowl.
At least one major league pitcher, about 20 professional soccer players
and perhaps hundreds of recreational athletes have also undergone the
procedure, commonly called platelet-rich plasma therapy.
Experts in sports medicine say that if the technique’s early
promise is fulfilled, it could eventually improve the treatment of
stubborn injuries like tennis elbow and knee tendinitis for athletes of all types.
Platelet Rich Plasma and Stem cells musculoskeletal treatment news
Σελίδες
▼
Σάββατο 28 Σεπτεμβρίου 2013
Platelet-Rich Plasma for Arthroscopic Repair of Large to Massive Rotator Cuff Tears A Randomized, Single-Blind, Parallel-Group Trial
Background:
Platelet-rich plasma (PRP) is expected to have a biological augmentation
potential in the healing of various diseases and
injuries, including rotator cuff tears. However,
few evaluations have been performed specifically for large to massive
tears.
Purpose: To assess the efficacy of PRP augmentation in patients undergoing arthroscopic repair for large to massive rotator cuff tears.
Study Design: Randomized controlled trial; Level of evidence, 1.
Methods: A total of 48
patients scheduled for arthroscopic repair of large to massive rotator
cuff tears were randomly assigned to
receive either PRP-augmented (PRP group) or
conventional treatment (conventional group). In the PRP group, 3 PRP
gels (3 ×
3 mL) were applied to each patient between the
torn end and the greater tuberosity. The primary outcome measure was the
retear
rate assessed by magnetic resonance imaging
(MRI) or computed tomographic arthrography (CTA) at a minimum of 9
months after
surgery. Secondary outcome measures included
pain, range of motion, muscle strength, overall satisfaction, functional
scores,
and the change in cross-sectional area (CSA) of
the supraspinatus.
Results: The retear rate of the PRP group (20.0%) was significantly lower than that of the conventional group (55.6%) (P = .023). Clinical outcomes showed no statistical difference between the 2 groups (all P > .05) except for the overall function (P = .043). The change in 1-year postoperative and immediately postoperative CSA was significantly different between the 2 groups:
–15.54 ± 94.34 mm2 in the PRP group versus −85.62 ± 103.57 mm2 in the conventional group (P = .047).
Conclusion: The
application of PRP for large to massive rotator cuff repairs
significantly improved structural outcomes, as evidenced
by a decreased retear rate and increased CSA of
the supraspinatus compared with repairs without PRP augmentation. While
there
was no significant difference in clinical
outcomes except the overall shoulder function after 1-year follow-up,
better structural
outcomes in the PRP group might suggest improved
clinical outcomes at longer term follow-up.
Blood therapy popular with pro athletes makes way to Cincinnati
A process that uses a patient’s own blood to help
speed the healing process is now being offered to treat tendon and
ligament injuries as well as degenerative joint arthritis by doctors who
specialize in orthopedics and sports medicine at the Christ Hospital
Health Network.
A blood separation system extracts platelet-rich plasma from a patient’s whole blood sample, according to Christ Hospital spokesman Michael Beauchat.
A blood separation system extracts platelet-rich plasma from a patient’s whole blood sample, according to Christ Hospital spokesman Michael Beauchat.
The Effect of Platelet-Rich Plasma on Clinical Outcomes in Lateral Epicondylitis.
Arthroscopy. 2013 Sep 20. pii: S0749-8063(13)00853-0. doi: 10.1016/j.arthro.2013.07.272. [Epub ahead of print]
The Effect of Platelet-Rich Plasma on Clinical Outcomes in Lateral Epicondylitis.
Source
Department of Orthopaedics, Norfolk and Norwich University Hospital, Norwich, England. Electronic address: zafar.ahmad@doctors.org.uk.Abstract
PURPOSE:
To evaluate the evidence for application of platelet-rich plasma (PRP) in lateral epicondylitis.METHODS:
We carried out a systematic review of the current evidence on the effects of PRP in lateral epicondylitis on clinical outcomes. We performed a comprehensive search of the PubMed, Medline, Cochrane, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and Embase databases using various combinations of the commercial names of each PRP preparation and "lateral epicondylitis" (with its associated terms), looking specifically at human studies. Data validity was assessed and collected on clinical outcome.Σάββατο 21 Σεπτεμβρίου 2013
Πλάσμα πλούσιο σε αιμοπετάλια (PRP), η θεραπεία μέσω της φύσης.
Η θεραπεία με πλάσμα πλούσιο σε αιμοπετάλια (PRP) ανήκει στις θεραπείες ενός νέου κλάδου της ιατρικής της αναγεννητικής ιατρικής "regenerative medicine", στόχος της οποίας είναι να διεγείρει τους φυσικούς μηχανισμούς θεραπείας του ίδιου του οργανισμού για να αποκαταστήσει αθεράπευτες βλάβες.
Οι επιστήμονες
προσπαθούσαν για πολλές δεκαετίες να ανακαλύψουν την ουσία
Platelet-Rich Plasma in the Pathologic Processes of Cartilage: Review of Basic Science Evidence
Purpose
The purpose of this study was to systematically review the basic science evidence for the use of platelet-rich plasma (PRP) in the treatment of pathologic processes of cartilage, both as an adjunct to cartilage repair and as a conservative management strategy for osteoarthritis, with the intent of determining the effect of PRP and whether a proof of concept for its use has been established to facilitate further investigation at a clinical level.Πέμπτη 12 Σεπτεμβρίου 2013
The healing power of blood
Tiger Woods and Kobe Bryant supposedly used it to get their stellar
bodies back in action. Angelina Jolie is said to have depended on it to
erase fine lines threatening her stellar face.
These superstars depended on platelet-rich plasma therapy, also known as protein-rich plasma or PRP, still considered experimental, but not for want of success in the fields of orthopedics, dentistry and even aesthetic treatments.
These superstars depended on platelet-rich plasma therapy, also known as protein-rich plasma or PRP, still considered experimental, but not for want of success in the fields of orthopedics, dentistry and even aesthetic treatments.